En Carta Diagnostics

En Carta Diagnostics is the developer of a biotechnology platform designed for molecular diagnostics through synthetic biology. The company’s platform offers ready-to-use tests against validated targets, as well as in-house development of new tools against virtually any DNA or RNA target using its patented technologies, enabling healthcare professionals to easily detect and identify infections.